JENNA KOCIS: Open Payments
NPI 1700656501 · DANBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,393 in 184 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $2,452 · 2025 $4,393
Food & beverage: $4,208Education: $185
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 51 | $947 |
| Janssen Biotech, Inc. | 20 | $540 |
| Incyte Corporation | 19 | $508 |
| UCB, Inc. | 13 | $501 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $382 |
| LEO Pharma Inc. | 13 | $311 |
| Galderma Laboratories, L.P. | 13 | $245 |
| PFIZER INC. | 13 | $229 |
| Lilly USA, LLC | 7 | $114 |
| Regeneron Healthcare Solutions, Inc. | 1 | $105 |
Products named: TREMFYA, OPZELURA, Bimzelx, SKYRIZI, RINVOQ, ADBRY, CIBINQO, Winlevi.
Industry payments across CT — which companies pay providers there.
